You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

News

Venture capital: RWE Generation invests in HTGF III

19. October 2017
RWE Generation SE has announced a strategic investment in High-Tech Gründerfonds’ third fund, HTGF III, which is launching with a planned volume of over EUR 300 million. High-Tech Gründerfonds (HTGF) is Germany’s most active seed stage investor. It provides financing for young, innovative technology-driven start-ups and actively supports them in implementing their business ideas. “Through this investment, we are seeking More …

High-Tech Gründerfonds (HTGF), MBG and Wayra invest EUR 800,000

12. October 2017
AI start-up 5Analytics receives follow-up financing 5Analytics, the start-up behind Telefónica Germany’s Analytical Insight Center (AIC), has secured a new round of financing from a prominent group of investors. The Stuttgart-based start-up plans to use the fresh capital to expand its team, develop its products and acquire new clients. In addition to Wayra, HTGF and MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg within More …

The game changer in surgical education – breaking bones for better patient outcomes

10. October 2017
Cologne based MedTech start-up RIMASYS received financing from investor HTGF. The investment will be utilized to expand the fracture portfolio, upgrade production technology and increase international reach. RIMASYS is the worldwide sole manufacturer of life-like fractures in human specimen with intact soft tissue mantle. Enabling medical science to enhance surgical skills and the health care industry to develop better implants More …

OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology

4. October 2017
OMEICOS adds REMIGES Ventures as new investor and announces the incorporation of U.S. subsidiary OMEICOS Ophthalmics, Inc. OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced that it has secured an extension of its recently closed Series B financing round. The financing by US-based REMIGES Ventures will help More …

BORN2GROW supports biotech start-up Venneos with its further growth

26. September 2017
Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells. “We are thrilled to have BORN2GROW on-board as a new investor, and that we will be able to benefit from its extensive expertise More …

Atriva reaches a development milestone and receives an additional tranche of running seed financing to develop its influenza therapeutic to clinical stage

21. September 2017
The next generation of Antiviral Therapies: Co-Led by Stichting Participatie Atriva and High-Tech Gründerfonds (HTGF), Atriva Therapeutics GmbH has received a second tranche of its running seed financing in total of € 3 Mn from Dutch, German and Canadian investors, after lead compound ATR-002 (Atriva’s antiviral MEK-Inhibitor against Influenza) has passed an important preclinical milestone paving the way to clinical More …

Coredinate secures follow-on financing

20. September 2017
New investor MWN Equity Investment and Bayern Kapital Innovationsfonds ERFE take stake Coredinate, a software-as-a-service (Saas) company based in Uffenheim, Bavaria, has successfully closed a €1.9 million financing round. Alongside existing investors such as High-Tech Gründerfonds, Bayern Kapital has invested in the firm once again – this time using funds from its innovation fund BayernKapital Innovationsfonds ERFE, which replaces SeedFonds More …

Evonik is investing in NUMAFERM, a specialist in the biotechnological production of peptides

18. September 2017
NUMAFERM makes the production of peptides more efficient Investment strengthens Evonik’s growth engines Health & Care and Specialty Additives at Evonik New technical applications are becoming realistic for the first time Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the spin-off of Heinrich Heine University Düsseldorf. The investment was More …

High-Tech Gründerfonds starts lining up investments for HTGF III fund

15. September 2017
Europe’s most active seed-stage investor announces first investments from third fund, HTGF III High-Tech Gründerfonds’ third fund is now operational After announcing the successful first close at the 2017 Family Day – the biggest event of the year for the venture capital sector in Germany – HTGF has now begun approving investments from the new fund. The launch coincides with More …

Reactive Robotics GmbH is on track

8. September 2017
Clinical validation, market entry in Germany and further countries secured by second investment round with existing and new investors Founded in 2015 in Munich, Reactive Robotics GmbH is a medical device start-up with the corporate objective to provide the best possible Very Early Mobilization (VEM) to intensive care patients as early as 24 hours after hospital admission, directly in the More …